Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|November 1, 1996
Treatment of high-risk myelodysplastic syndromes with lymphoblastoid alpha interferonM C Petti, R Latagliata, G Avvisati, et al.
Haematologica|March 1, 1989
Acute nonlymphocytic leukemia in the elderly: results of a retrospective studyR Latagliata, C Sgadari, F Pisani, et al.
Haematologica|November 1, 1993
Erythropoietin treatment of idiopathic myelofibrosisM Aloe Spiriti, R Latagliata, G Avvisati, et al.
Leukemia Research|March 1, 1995
Is aggressive chemotherapy the best choice for patients with acute nonlymphocytic leukemia after myelodysplastic syndromes?R Latagliata, M A Spiriti, G Avvisati, et al.
Pharmacological Research|September 16, 2000
A case-control study of the effects of hydroxyurea on circulating cortisol levels in patients with acute myelogenous leukemia and chronic myeloproliferative disordersP Navarra, M A Aloe-Spiriti, F Boccarini, et al.
Leukemia|June 25, 1998
Polycythemia vera treated with pipobroman as single agent: low incidence of secondary leukemia in a cohort of patients observed during 20 years (1971-1991)M C Petti, A Spadea, G Avvisati, et al.
Cancer|March 1, 1978
Lack of prognostic significance of the pretreatment labeling and mitotic indices of marrow blasts in acute nonlymphocytic leukemia (ANLL)S Amadori, M C Petti, A De Francesco, et al.
Leukemia Research|January 1, 1984
Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphomaS Amadori, G Papa, G Avvisati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemiaS Amadori, W Arcese, G Isacchi, et al.
Scandinavian Journal of Infectious Diseases|September 13, 2011
Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapyL Nosotti, M D'Andrea, A Pitidis, et al.
Pageof 11